GlassScriptPhysician profile
Matthew W Ebinger
NPI 1225087448
$36,159.77
in general payments reported to CMS, 2019-2025
20 companies · $1,460 in 2025
The $1,460 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $2,029 · 2021: $86.49 · 2022: $4,294 · 2023: $1,265 · 2024: $7,811 · 2025: $1,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,786 · Food and Beverage: $4,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,786.03 |
| Food and Beverage | $4,749.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $14,625.94 | 2019-2024 | Carto 3 |
| Biosense Webster, INC. | $10,379.20 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Medtronic, INC. | $7,776.23 | 2022-2025 | Micra, Cobalt Dr Mri Surescan, Linq II |
| Boston Scientific Corporation | $1,084.26 | 2021-2025 | Watchman Access System, Watchman Flx, Endotak Reliance S |
| Medtronic Vascular, INC. | $1,056.85 | 2019-2020 | |
| Biotronik INC. | $377.05 | 2019-2024 | Acticor 7 Vr-T Dx |
| Abbott Laboratories | $298.93 | 2019-2022 | |
| Philips North America LLC | $175.22 | 2024-2025 | Igt Devices Undivided, (O49) Image Guided Therapy Und |
| Ge Healthcare | $158.67 | 2023 | |
| Cordis US Corp. | $43.79 | 2024-2025 | Mynx Control, Mynx Control Venous |
| Lundbeck LLC | $43.73 | 2019 | |
| Elutia, INC. | $24.68 | 2021 | |
| Cardiva Medical, INC. | $23.85 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $21.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.65 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.04 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.91 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.27 | 2019 | |
| Pfizer INC. | $10.83 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ebinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.